PROM1 and central nervous system cancer: LPS-activated TLR4 signaling promotes the proliferation and chemoresistance of glioma CD133+ CSCs and triggers the release of various cytokines, resulting in the resistance of glioma CD133+ CSCs to CTL-induced lysis.